Schedule 13D ownership disclosure
ALPINE IMMUNE SCIENCES INC
Security class unavailable · CUSIP: 02083G100
Event date: 2019-01-18
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 21.8000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-19-014248
- Form type
- SC 13D
- Filer
- ALPINE IMMUNE SCIENCES, INC.
- CIK
- CIK 1626199
- Filed
- Jan 23, 2019
- Reporting period
- Jan 18, 2019
- Description
- Schedule 13D beneficial ownership